Teleflex wins expanded FDA clearance for PAD device

08/2/2013 | (Boston)

The FDA has granted Teleflex clearance for new versions of its Arrow GPSCath Balloon Dilatation Catheter that have 80-centimeter lengths and higher burst-pressure ratings. The device, which was acquired by Teleflex through its acquisition of Hotspur Technologies last year, is used to treat patients with peripheral artery disease.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Health Plan Operations
Group Health Cooperative
Seattle, WA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Vice President, Idaho Regional Director
Boise, ID
Counsel II, Legal (Anti-corruption)
Gilead Sciences
Foster City, CA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA